Artikel ; Online: A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections.
2024 Band 15, Heft 1, Seite(n) 3021
Abstract: Preterm birth is currently the leading cause of neonatal morbidity and mortality. Genetic, immunological and infectious causes are suspected. Preterm infants have a higher risk of severe bacterial neonatal infections, most of which are caused by ... ...
| Abstract | Preterm birth is currently the leading cause of neonatal morbidity and mortality. Genetic, immunological and infectious causes are suspected. Preterm infants have a higher risk of severe bacterial neonatal infections, most of which are caused by Escherichia coli an in particular E. coli K1strains. Women with history of preterm delivery have a high risk of recurrence and therefore constitute a target population for the development of vaccine against E. coli neonatal infections. Here, we characterize the immunological, microbiological and protective properties of a live attenuated vaccine candidate in adult female mice and their pups against after a challenge by K1 and non-K1 strains of E. coli. Our results show that the E. coli K1 E11 ∆aroA vaccine induces strong immunity, driven by polyclonal bactericidal antibodies. In our model of meningitis, mothers immunized prior to mating transfer maternal antibodies to pups, which protect newborn mice against various K1 and non-K1 strains of E. coli. Given the very high mortality rate and the neurological sequalae associated with neonatal E. coli K1 meningitis, our results constitute preclinical proof of concept for the development of a live attenuated vaccine against severe E. coli infections in women at risk of preterm delivery. |
|---|---|
| Mesh-Begriff(e) | Infant ; Adult ; Infant, Newborn ; Female ; Animals ; Mice ; Humans ; Escherichia coli/genetics ; Vaccines, Attenuated ; Premature Birth/prevention & control ; Infant, Premature ; Escherichia coli Infections/prevention & control ; Infant, Newborn, Diseases/etiology ; Antibodies ; Meningitis/etiology |
| Chemische Substanzen | Vaccines, Attenuated ; Antibodies |
| Sprache | Englisch |
| Erscheinungsdatum | 2024-04-08 |
| Erscheinungsland | England |
| Dokumenttyp | Journal Article |
| ZDB-ID | 2553671-0 |
| ISSN | 2041-1723 ; 2041-1723 |
| ISSN (online) | 2041-1723 |
| ISSN | 2041-1723 |
| DOI | 10.1038/s41467-024-46775-x |
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.